Monthly Archives: July 2020

Anatomy

Greys Anatomy season 17: Meredith soon in a relationship with Jackson ? – The Saxon

Share on Facebook

Season 17 of Greys Anatomy is in preparation. Meredith is no longer in a relationship with DeLuca, and she could end up with Jackson.

Fans of Greys Anatomy and eagerly await season 17. Meredith could very well end up hanging out with Jackson. Beware, the article contains spoilers.

Season 16 of Greys Anatomy has had some concerns because of the Covid-19. As well, the fans have not been able to see the last episodes of the season. In fact, they are stuck in post-production and the season was closed earlier than expected.

Nevertheless, it has happened a lot of things in this season. In fact, Meredith has put an end to his story with DeLuca. The young doctor realized that she really wasnt in love with him.

In addition, Andrew appears to have some health concerns and he will have to deal with that in season 17. On his side, the mother of Zola has made the acquaintance of a new doctor : Cormac Hayes. It does not seem indifferent to its charm, but they will surely not together.

In fact, it could be that the doctor gets closer to Jackson in season 17 of Greys Anatomy. Thus, we imagine very well together !

This makes many years that Jackson and Meredith are working together, and they are excellent in their craft. In addition, the two characters have both experienced large tragedies in their lives and Jackson is divorced.

Just like Meredith, Jackson has to juggle between his professional life and his child. Because of this, they have many points in common , and they can count on each other. Even if we see very little together in Greys Anatomy, there is no doubt that they are very close.

Jackson could be the ideal candidate to Meredith and they would go very well together. In any case, it would be nice to see a little flirting between the two of them in the next season of Greys Anatomy.

Nevertheless, for the moment, Jackson seems to have had a blow of heart for a pompire of Station 19. Thus, it remains unlikely that the two doctors end up going out together.

See the original post:
Greys Anatomy season 17: Meredith soon in a relationship with Jackson ? - The Saxon

Physiology

The College of St. Scholastica announces students named to the spring 2020 Dean’s List – Brainerd Dispatch

Spring 2020 Dean's List recipients include the following local students (listed alphabetically):

Laura Anderson of Longville. Anderson is majoring in Organizational Behavior.

Diana Banks of Emily. Banks is majoring in Social Work.

Elizabeth Becker of Little Falls. Becker is majoring in Nursing.

Katelyn Becker of Pierz. Becker is majoring in Music Education.

Taryn Becker of Brainerd. Becker is majoring in Exercise Physiology.

Alexandra Benning of Browerville. Benning is majoring in Social Work.

Izabella Bishop of Hill City. Bishop is majoring in Elementary Education.

Jenna Butler of Bowlus. Butler is majoring in Nursing.

Grace Carlson of Isle. Carlson is majoring in Biochemistry - Intended.

Jonathan Carlson of Motley. Carlson is majoring in Nursing.

Seth Crocker of Little Falls. Crocker is majoring in Psychology.

Kara Crowther of Aitkin. Crowther is majoring in Health Information Management.

Lisa Dailey of Verndale. Dailey is majoring in Nursing.

Jennifer Dolezal of Staples. Dolezal is majoring in Organizational Leadership.

Macy Dotty of Pequot Lakes. Dotty is majoring in Health Information Management.

Ashley Etter of Sebeka. Etter is majoring in Philosophy - Intended.

Josie Fourre of Albany. Fourre is majoring in Nursing.

Melissa Geisenhof of Little Falls. Geisenhof is majoring in Nursing.

Mariah Haukos of Ironton. Haukos is majoring in Nursing.

Kendal Hendrickson of Little Falls. Hendrickson is majoring in Psychology.

Janna Heurung of Little Falls. Heurung is majoring in Nursing.

Nathaniel Hilton of Hill City. Hilton is majoring in Art - Intended.

Sydney Holt of Crosslake. Holt is majoring in Nursing.

Kalie Jeremiason of Pine River. Jeremiason is majoring in Undeclared.

Jaren Johnson of Aitkin. Johnson is majoring in Health Humanities Intended.

Bethany Kinzer of Aitkin. Kinzer is majoring in Educational Studies.

Thomas Kunkel of Little Falls. Kunkel is majoring in Exercise Physiology - Intended.

Addison Lintner of Little Falls. Lintner is majoring in Nursing - Intended.

Bailey Lochner of Pierz. Lochner is majoring in Exercise Physiology - Intended.

Morgan Lohmiller of Crosslake. Lohmiller is majoring in Nursing.

Sannah Lohmiller of Crosslake. Lohmiller is majoring in Psychology.

Sophia Magnuson of Aitkin. Magnuson is majoring in Elementary Education.

Kate Miller of Randall. Miller is majoring in English.

Maria Moe of Royalton. Moe is majoring in Biology - Intended.

Ramsey Moe of Aitkin. Moe is majoring in Business Management.

Abigail Mokhtary of Flensburg. Mokhtary is majoring in Nursing.

Nicole Nelson of Akeley. Nelson is majoring in Nursing - Intended.

Oscar Norgren of Little Falls. Norgren is majoring in Nursing - Intended.

Elizabeth Olmscheid of Breezy Point. Olmscheid is majoring in Nursing - Intended.

Rainy Orazem of Isle. Orazem is majoring in Nursing - Intended.

Danielle Overman of Albany. Overman is majoring in Exercise Physiology - Intended.

Amy Pasket of Nisswa. Pasket is majoring in Psychology.

Carson Passer of McGregor. Passer is majoring in Finance.

Abby Pohlkamp of Baxter. Pohlkamp is majoring in Accounting.

Gabriel Raguse of Brainerd. Raguse is majoring in Exercise Physiology.

Benjamin Renner of Brainerd. Renner is majoring in Exercise Physiology - Intended.

Dan Roach of Merrifield. Roach is majoring in Business Management.

Mara Roberts of Brainerd. Roberts is majoring in Elementary Education.

Morgan Rohloff of Brainerd. Rohloff is majoring in Psychology.

Brock Ronnebaum of Baxter. Ronnebaum is majoring in Social Science Secondary Edu.

Noah Ross of Wadena. Ross is majoring in Biology - Intended.

Christina Sabrowsky of Albany. Sabrowsky is majoring in Nursing.

Patricia Samuelson of Baxter. Samuelson is majoring in Social Work.

Nancy Schroeder of Pequot Lakes. Schroeder is majoring in Social Work.

Alyvia Seibert of Deer River. Seibert is majoring in Biology - Intended.

Jack Silgen of Deerwood. Silgen is majoring in Business Management.

Zachary Sjoblad of Nisswa. Sjoblad is majoring in Health Information Management.

Connor Skeesick of Little Falls. Skeesick is majoring in Biology - Intended.

Karli Skog of Crosslake. Skog is majoring in Accounting.

Madison Slette of Aitkin. Slette is majoring in Nursing - Intended.

Grace Stockard of Fort Ripley. Stockard is majoring in Nursing - Intended.

Evan Storbakken of Brainerd. Storbakken is majoring in Psychology.

Nicholas Trelstad of Mc Grath. Trelstad is majoring in English Sec. Ed.

Tyler Weiss of Browerville. Weiss is majoring in Nursing.

Samantha Welle of Royalton. Welle is majoring in Nursing.

Hannah Wiedewitsch of Jenkins. Wiedewitsch is majoring in Biology.

Claudina Williams of Pequot Lakes. Williams is majoring in Psychology.

Evan Wohlert of Baxter. Wohlert is majoring in Exercise Physiology.

Cheryl Zimmerman of Bowlus. Zimmerman is majoring in Hlth Info Mgt - Intended.

See original here:
The College of St. Scholastica announces students named to the spring 2020 Dean's List - Brainerd Dispatch

Physiology

Higgins announces $2.2 million grant to UB to support Parkinson’s research – UB Now: News and views for UB faculty and staff – University at Buffalo…

Rep. Brian Higgins has announced that UB has received a five-year, $2,224,925 grant from the National Institutes of Health to develop a method to diagnose Parkinsons disease (PD) before clinical symptoms are present.

The funding was awarded by the National Institute of Neurological Disorders and Stroke of the NIH. Principal investigator is Jian Feng, professor of physiology and biophysics in the Jacobs School of Medicine and Biomedical Sciences at UB.

Parkinsons is a motor system disorder resulting from the loss of dopamine-producing cells in the brain. It currently is diagnosed by neurologists observing and rating clinical symptoms based on a standard criteria. To even exhibit the onset of clinical symptoms of PD, one must experience many decades of cellular deterioration.

UBsresearch aims to transform Parkinsons research and therapeutic development with the ability to diagnose PD earlier, allowing for the possibility of proactively preventing or delaying severe neuron decay. The research, titled Molecular Segregation of Parkinsons Disease by Patient derived Neurons will also aim to identify and separate two major subtypes of PD those who experience tremors and those who do not to be able to better treat specific types of PD.

The National Institutes of Health estimates that up to 1 million people in the United States may have Parkinsons disease. Thats 1 million Americans with a difficult, progressive condition without a cure who must wait until their clinical symptoms are serious enough to be diagnosed, Higgins said. This federal investment to assist our Western New York researchers hopes to provide a path to earlier detection of Parkinsons to attempt treatment as quick as possible.

When we generated induced pluripotent stem cells from a group of Parkinsons disease patients and a group of normal subjects, we found that there were many significant differences in the expression levels of genes controlling the production, utilization and degradation of dopamine, Feng said. Thus, we want to investigate this further with the goal of developing a method for the objective diagnosis of Parkinsons disease. It might also allow us to predict years in advance who may develop Parkinsons.

Higgins has been an advocate for measures that advance Parkinsons research and treatment.Following meetings with the Michael J. Fox Foundation,the Parkinsons Foundation of WNY and local advocate and former congressman Jack Quinn, Higgins sent a letter to the Department of Veterans Affairs and the Department of Health and Human Services last January urging that access to boxing therapy in the treatment of Parkinsons be expanded, as well as more research be conducted to document the efficacy of the program.In February, he drafted a bipartisan letter supporting funding for a surveillance database at the Centers for Disease Control and Prevention to collect vital demographic information on people living with neurological diseases,a measure supported by the Michael J. Fox Foundation.

View original post here:
Higgins announces $2.2 million grant to UB to support Parkinson's research - UB Now: News and views for UB faculty and staff - University at Buffalo...

Physiology

The Benefits of Heat Training, Reconsidered | Outside Online – Outside

This is the time of year when fitness journalists write articles about how the miserable heat thats ruining your workouts is actually doing you a big favor. Youre lucky to be dripping buckets of sweat and chafing up a storm, because heat is the poor mans altitude, ramping up the physiological demands of your workout and triggering a series of adaptations that enhance your endurance.

Heres the version of that story that I wrote two summers ago, and Im sticking to it. But I may need to update the rationale for why heat is so great, based on a new study in Experimental Physiology. According to a research team led by Carsten Lundby and Bent Rnnestad at Inland University of Applied Sciences in Norway, heat boosts levels of oxygen-carrying hemoglobin in your blood, just like altitude trainingbut its not a quick fix.

One of the key determinants of endurance performance is how quickly you can ferry oxygen from your lungs to your muscles via your blood. Specifically, its the hemoglobin in your red blood cells that grabs the oxygen. Spend a few weeks at high altitude, where the air is thin, and your body responds by generating more hemoglobin. Thats why the vast majority of elite endurance athletes do altitude training.

Heat training works differently. The most notable change, after just a few days, is a dramatic increaseof up to 20 percentin the volume of plasma coursing through your veins. Thats the part of the blood that doesnt include hemoglobin-rich red blood cells, so its not immediately obvious whethermore plasma will enhance your endurance under moderate weather conditions. In fact, theres an ongoing debate among scientists on precisely that question. One theory, for example, is that the extra plasma dilutes the accumulation of lactate during hard exercise. (But theres no doubt that it boosts performance in hot conditions: the extra plasma volume helps shunt excess heat to your skin, among other things.)

When The Journal of Physiology hosted a debate a few years ago on whether heat training boosts performance in moderate conditions, the coauthor of the paper arguing against the proposition was none other than Carsten Lundby. He doesnt buy the claim that more plasma is useful on its own.

But for the past few years, Lundby and his colleagues have been considering another possibility. The extra plasma volume has the effect of diluting the concentration of red blood cells in your blood, a quantity known as your hematocrit. If your total blood is made up of 45 percent red blood cells by volume, your hematocrit is 45. If heat training causes your plasma volume to increase, that will lower your hematocrit.

Lundbys hypothesis is based on the idea that your kidneys are constantly monitoring hematocrit, trying to keep it in a normal range. If your hematocrit has a sustained decrease, the kidney responds by producing EPO to trigger the production of more hemoglobin-rich red blood cells. Unlike the rapid increase in plasma volume, this is a slower process. Lundby and his colleagues figure it could take about five weeks.

He and his colleagues published some initial results back in November in Frontiers in Physiology. After five and a halfweeks, 12 trained cyclists doing an hour of heat training five days a week (incorporated into their regular training) did indeed show a small hemoglobin increase compared to a matched group of nine cyclists doing the same training in cooler conditions. But there was a lot of individual variation in the results, possibly because the subjects werent all at the same level of fitness.

For the new study, they recruited truly elite cyclists with an average VO2 max of 76.2 milliliters of oxygen per kilogram of body weight per minute. They were training about tenhours a week during the five-week study, and into that regimen, they incorporated five afternoon sessions of 50 minutes of light exercise on a stationary bike. The 11 cyclists in the heat group did those sessions in about 100 degrees and 65 percent humidity; the 12 cyclists in the control group did the same sessions at 60 degrees and 25 percent humidity, aiming for the same subjective effort level. During the heat sessions, the cyclists were limited to half a liter of water to ensure mild dehydration, which is thought to be one of the triggers for plasma volume expansion.

The key outcome measure: total hemoglobin mass increased 893 to 935 grams in the heat group, a significant 4.7 percent increase. In the control group, hemoglobin mass stayed essentially unchanged, edging up by just 0.5 percent. Heres how the individual results looked:

(Illustration: Experimental Physiology)

The study also included a bunch of physiology and performance tests, including VO2 max, lactate threshold, and a 15-minute time trial. There were no statistically significant differences between the groups, but several of the outcomes did show small to intermediate effect sizes favoring the heat group. For example, the heat group increased power output at lactate threshold by 2.8 percent, while the control group decreased by 0.4 percent. Also, the heat group increased average power during the 15-minute trial by 6.9 percent, while the control group improved by 3.4 percent.

All in all, the results are cautiously encouraging. They dont prove that Lundbys hypothesis about diluted blood stimulating more EPO is what caused the changes, but they suggest that something good seems to happen after about five weeks.

Thats good news, but its also a problem, in a way. One of the reasons that heat training has garnered so much attention over the past few years is that its relatively practical and accessible. Only a tiny fraction of the worlds athletes can spend a month in the Alps before every major race. But lots of people can go heat-training just by stepping out the front dooror even, according to some studies, by lounging in the hot tub or sauna after workouts.

Committing to five long weeks of miserable, sticky heat training is a bigger ask, though. Lundby and his colleagues acknowledge this limitation, noting that this type of training may only serve little relevance in amateur sport. Still, for those looking for every possible edge, the results will undoubtedly attract attention. And for those living in places like Texas (or even supposedly cooler parts of the continent, like Toronto, where I live, which has started the summer with an oppressive streak of heat warnings), its much needed consolation. You may not have chosen to undergo week after week of heat training, but at least you might get some hemoglobin out of it.

For more Sweat Science, join me on Twitter and Facebook, sign up for the email newsletter, and check out my book Endure: Mind, Body, and the Curiously Elastic Limits of Human Performance.

Our mission to inspire readers to get outside has never been more critical. In recent years, Outside Online has reported on groundbreaking research linking time in nature to improved mental and physical health, and weve kept you informed about the unprecedented threats to Americas public lands. Our rigorous coverage helps spark important debates about wellness and travel and adventure, and it provides readers an accessible gateway to new outdoor passions. Time outside is essentialand we can help you make the most of it. Making a financial contribution to Outside Online only takes a few minutes and will ensure we can continue supplying the trailblazing, informative journalism that readers like you depend on. We hope youll support us. Thank you.

When you buy something using the retail links in our stories, we may earn a small commission. Outside does not accept money for editorial gear reviews. Read more about our policy.

You are now subscribed to We will not share your email with anyone for any reason.Find more newsletters on our newsletter sign-up page.

Follow this link:
The Benefits of Heat Training, Reconsidered | Outside Online - Outside

Physiology

Sea lice prevention better than the cure – Feedstuffs

Sea lice management is a stressful task for salmon and salmon farmers. In a new article titled "Prevention Not Cure: A Review of Methods to Avoid Sea Lice Infestations in Salmon Aquaculture," researchers from the University of Melbourne, the Norwegian Institute of Marine Research and Nofima argue that methods to prevent sea louse infestations have some key advantages over other strategies, and they identify the most promising preventative methods, according to an announcement from Nofima, a Norway-based institute focused on fisheries, aquaculture and foods research.

Currently, salmon farmers have options to manage lice by preventing infestations, continuously controlling infestations to keep lice at low levels or waiting until infestations reach "trigger" levels and then carrying out immediate delousing, Nofima said.

The report authors explained that effectively preventing infestations before they occur causes less stress for the salmon and fewer production losses, as farmers avoid the need for delousing treatments.

The major delousing methods subject the salmon and the lice to the same unpleasant experience. They work because the salmon usually survive the experience, and the sea lice do not. Preventative methods avoid this situation by targeting lice before they attach to the host or by helping salmon fight off lice larvae at the moment of attachment, said lead author Dr. Luke Barrett from the University of Melbourne in Australia.

What are the most effective methods to prevent sea louse infestations?

The researchers trawled through the data from all published tests of sea lice prevention and identified the most effective methods, Nofima said, reporting that the best approach is to keep lice out of sea cages using mesh or tarpaulin barriers: Lice skirts prevented 55% of infestations, while snorkel cages prevented 76%. These methods can make the job of controlling lice much more manageable, while fully enclosing cages is more difficult but can be up to 100% effective.

However, lice barriers are not suitable at all locations, Nofima said, such as where there are strong currents or low oxygen levels. In such cases, other more widespread preventative methods are worth trying, such as encouraging salmon to swim below the most common depth for sea lice, improving the immunity of salmon using breeding or functional feed additives and using repellents or masking scents to stop lice from being attracted to salmon.

Most preventative methods leverage our knowledge of the natural behaviors and physiology of salmon and lice, such as their preferred swimming depths, to reduce the likelihood of salmon encountering lice and becoming infected, said co-author Tim Dempster from the University of Melbourne.

What does the future hold?

Fish farming companies, especially in Norway, are beginning to invest more heavily into preventive methods such as skirts and snorkel cages as well as continuous control methods to avoid having to delouse. The authors said they expect this trend to continue.

Crucially, susceptibility to sea lice is a genetic trait that is passed on to offspring, Nofima said. Accordingly, some researchers and farming companies have also made progress on breeding more lice-resistant salmon while work on a cost-effective vaccine continues.

Selective breeding against sea lice is a long-term strategy that will likely bring significant benefits in the future, said co-author Dr. Nick Robinson, a senior researcher at Nofima.

The research was published in Reviews in Aquaculture.

Excerpt from:
Sea lice prevention better than the cure - Feedstuffs

Physiology

Lifestyle, Age, and Sex Affect Several Biophysical Properties of the Skin – Dermatology Advisor

Diet, sleeping habits, age, and sex may predict the nature of the skins sebum content, subcutaneous hydration, and pH. This is according to study data published in the Journal of Cosmetic Dermatology.

The study enrolled 300 volunteers between the ages of 20 and 69 years. Trained resident doctors administered a standardized questionnaire that asked participants about their dietary intake, whether or not they stayed up late, and time spent using electronics (eg, mobile phones and computers). A multifunctional skin physiology monitor was used to measure 3 skin biophysical properties on the dorsal hand and the forehead. A Sebumeter measured skin sebum, a Corneometer measured stratum corneum hydration, and a pH meter measured skin surface pH. Dermatologists performed all measurements a total of 3 times each to obtain an average value.

Approximately 65% of the volunteers said they go to bed after 11 pm, and up to half of respondents said they go to bed after 1 am. Only 6% of participants said they spend <3 hours a day on electronic products. More than 70% of study volunteers said they eat spicy food >3 times a week and greasy food >2 times per week. Almost half of participants reported that they eat sweets 2 times a week.

Participants between the ages of 25 and 29 years had significantly higher sebum content on the forehead compared with those between the ages of 20 and 24 years and >40 years. The sebum content on the forehead was also higher for those between the ages of 30 and 39 years than those between the ages of 40 and 49 years. Forehead sebum content was also significantly lower in women than it was in men.

The sebum content on the forehead significantly increased in relation to the increased number of times participants reported eating oily and spicy foods. Eating sweets twice a week was associated with the highest sebum content on the forehead compared with not eating sweets or eating sweets only 1 time per week and somewhat higher than eating sweets 3 times per week.

In addition, forehead sebum content was higher in the group of respondents who went to bed after 1 am compared with those who went to bed before 11 pm. Lower sebum content on the forehead was also associated with the use of electronic products for only 3 to 6 hours per day.

Subcutaneous hydration of the dorsal hand was highest in people who reported eating more sweet and oily foods. Also, subcutaneous hydration on the forehead was highest in participants who said they ate more sweet food and went to bed before 11 pm compared with after 1 am. An increased skin surface pH on the forehead and dorsal hand was associated with age, and more women than men had a higher skin surface pH. In contrast, the use of electronic products for >6 hours a day and staying up until 1 am were associated with reduced forehead pH levels.

Limitations of the study included its relatively small sample size as well as the reliance on lifestyle information that was obtained from questionnaires.

The researchers of the study wrote that the observed skin-related differences in lifestyles, ages, and sex may be related to the individual susceptibility to skin diseases, and the findings may have important reference value for people to improve their skin by changing their daily behavior habits.

Reference

Zhao C, Wang X, Mao Y, et al. Variation of biophysical parameters of the skin with age, gender, and lifestyles [published online April 25, 2020]. J Cosmet Dermatol. doi: 10.1111/jocd.13453

Go here to see the original:
Lifestyle, Age, and Sex Affect Several Biophysical Properties of the Skin - Dermatology Advisor

Physiology

Mezzion Announces Submission of New Drug Application for its Orphan Drug Udenafil to Treat Patients who have undergone the Fontan Operation for Single…

SEOUL, South Korea, June 30, 2020 /PRNewswire/ --Mezzion Pharma Co. Ltd. (140410.KQ), announced today that it has submitted a New Drug Application (NDA) to theU.S. Food and Drug Administration(FDA) for the approval of udenafil toimprove the physiology of patients 12 years of age and older with single ventricle heart disease (SVHD) who have undergone the Fontan operation. Udenafil is a long acting highly selective phosphodiesterase-5 inhibitor that is orally administered. The NDA includes a request for Priority Review, which, if granted, may shorten the FDA's review of the NDA to six months from the time of filing, versus a standard review timeline of 10 months from filing.

The NDA submission, which totals nearly 100,000 pages, is supported by data from more than 700 documents including more than 200 studies that Mezzion has completed during the last 2 decades since its founding in 2002. The NDA package includes a pivotal Phase 3 clinical study conducted globally in close collaboration with the Pediatric Heart Network (PHN), which is funded by a grant from the National Heart, Lung, and Blood Institute (NHLBI). This was the largest pharmacotherapeutic study ever to be conducted in those with a congenital heart condition and involved the recruitment and treatment of 400 male and female adolescents from 30 PHN and auxiliary sites throughout the U.S.A., Canada, and the Republic of Korea. The results of this study, the Fontan Udenafil Exercise Longitudinal (FUEL) trial, were published in Circulation (December 2019) abstract #20942 . https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.119.044352

The American Heart Association (AHA) recognized Mezzion's FUEL trial as the biggest victory in congenital heart disease (CHD) advancement for 2019. Dr. Stephen Paridon, the principal investigator of the FUEL trial had the following comment, "The unique collaboration between Mezzion and the PHN allowed for the successful completion of the FUEL trial, a study that demonstrated an important effect of udenafil on exercise performance and heart function in those born with SVHD."

The results of the landmark FUEL trial demonstrated statistically significant improvements in multiple measures of exercise performance and cardiac function in patients treated with udenafil who had undergone the Fontan operation. The improvements in exercise were most pronounced at moderate levels of activity while the improvement in cardiac function was determined using the myocardial performance index, a standard echocardiographic measurement technique.

Dr. James Yeager, Chief Operating Officer of Mezzion Pharmaceuticals Inc., commented,"This large-scale Phase 3 study for an orphan disease indication using a drug designated for a rare pediatric disease took five years to complete and was challenging to execute. We owe a major debt of gratitude to all of the patients who participated in the study, their parents and the clinical investigators who led the study. Our thanks also go out to the PHN and the NHLBI along with a countless number of consultants, contract research and manufacturing organization partners. We now look forward to the potential approval and launch of udenafil over the next year. If approved, udenafil would provide the first and only approved therapy for this underserved population of patients."

Jodi Smith, Esq., Program Director for Mended Hearts and Mended Little Hearts, a USA-based advocacy group for patients with heart disease and their families, states, "As a parent of a child with Fontan palliation who had participated in this study, I am encouraged to see the results that show improvement in day-to-day life activities. I have seen this improvement firsthand in my son. I am also glad to see that the clinical data seem to show improvement in numbers that impact heart function and decrease heart failure. All of this, together, can improve the quality of life for single-ventricle patients like my son."

Mezzion looks forward to the FDA review process and to bringing a novel pharmacotherapeutic option to this unique patient population. Dr. David Goldberg, co-Principal Investigator summed it up nicely. "After years of borrowing medical therapies from the adult heart failure experience, we finally have a drug that specifically targets the unique physiology of SVHD after Fontan palliation."

About the Fontan Procedure and Subsequent Expectations

The Fontan procedure is a surgical intervention that allows for the survival of children born with congenital heart disease characterized by only a single functional pumping chamber. This procedure consists of re-configuring the circulation to allow the single ventricle to pump blood to the body while connecting the great veins directly to the arteries that bring blood to the lungs. In this "Fontan circulation" the blood returning from the body bypasses the heart and travels to the lungs without the presence of a right ventricle pumping chamber. The goal of the Fontan procedure is to separate the systemic and pulmonary circulations and to improve oxygen levels by redirecting venous blood directly to the lungs.

While the Fontan procedure creates a stable circulation, the risk of hospitalization and cardiac death rises significantly in the second and third decades after Fontan completion, a risk that is associated with a decline in exercise capacity. The Fontan circulation is also associated with non-cardiac complications such as protein-losing enteropathy, plastic bronchitis, and liver failure, all of which can be attributed to a chronic elevation in central venous pressure and a chronically reduced cardiac output. For all of these reasons, a 35 year-old patient who has gone through Fontan palliation has the approximate life expectancy of a 75 year old with normal cardiac physiology.

Mezzion Pharma Co., Ltd.

Mezzion Pharma Co., Ltd. is headquartered in Korea. Mezzion and its wholly owned subsidiary, Mezzion Pharmaceuticals, Inc., have administrative offices in Deerfield, Illinois and Boca Raton, Florida. Mezzion Pharma is an innovation-driven pharmaceutical company that is focused on discovering, developing, and commercializing novel therapeutics in the field of rare pediatric diseases. Mezzion Pharma is a publicly-listed pharmaceutical company in Korea on the Korean stock exchange under (140410:KOSDAQ).

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding: Mezzion Pharma's expectations regarding the potential benefits of udenafil; Mezzion Pharma's expectations regarding the anticipated timing of any future clinical trials; Mezzion Pharma's expectations on regulatory submissions for marketing approval of udenafil for the treatment of patients that have undergone the Fontan operation, to improve exercise capacity in the United States, including the timing of these submissions; and Mezzion Pharma's expectations regarding the potential commercial launch of udenafil, including the timing of a potential approval of udenafil. Risks and uncertainties that contribute to the uncertain nature of the forward-looking statements include: the expectation that Mezzion Pharma will need additional funds to finance its operations; Mezzion Pharma's or any of its collaborative partners' ability to initiate and/or complete clinical trials; the unpredictability of the regulatory process; the possibility that Mezzion Pharma's or any of its clinical trials will not be successful; Mezzion Pharma's dependence on the success of udenafil; Mezzion Pharma's reliance on third parties for the manufacture of Mezzion Pharma's udenafil and udenafil tablets; possible regulatory developments in the United States and foreign countries; and Mezzion Pharma's ability to attract and retain senior management personnel.

These and other risks and uncertainties are described more fully in Mezzion Pharma's most recent filings with the Statements under the Private Securities Litigation Reform Act: with the exception of the historical information contained in this release, the matters described herein contain forward-looking statements that involve risk and uncertainties that may individually or mutually impact the matters herein described, including but not limited to FDA review and approval, product development and acceptance, manufacturing, competition, and/or other factors, which are outside the control of Mezzion Pharma. All forward-looking statements contained in this press release speak only as of the date on which they were made. Mezzion undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

Contact:Dr. James Yeager, Deerfield, Illinois, USA, Tel: +1-847-2122679 Email:[emailprotected]Mr. YT Song, Seoul, Korea, Tel: +82 2 560 8011Email:[emailprotected]

SOURCE Mezzion Pharma Co. Ltd.

See the article here:
Mezzion Announces Submission of New Drug Application for its Orphan Drug Udenafil to Treat Patients who have undergone the Fontan Operation for Single...

Physiology

These judges have opened a can of worms – The Herald

To the editor:

Recently, Justice Kavanaugh and Chief Justice Roberts betrayed their duty as originalists jurists by reinterpreting sex in the Title VII Civil Rights Act, acting as legislators. These judges have opened a can of worms.

Women and girl athletes will face cheating on the tracks and fields having to compete with men's superior physiology. Bakers and photographers will be forced to violate their beliefs and forced out of business, as will educators and others. These are the people who the judges betrayed.

When the protests were ramping up in New York City, pro-life advocates Bevelyn Beatty and Edmee Chavannes, co-founders of At the Well Ministries, were arrested standing in front of a Planned Parenthood clinic for violating Governor Como and the Communist mayors social distancing policies. At this time, the George Floyd protesters and the looters were taking advantage of the chaos. They were packed in like sardines.

During the lockdown, we couldnt go to church for fellowship, but mothers could kill their babies. People could go to the liquor stores and visit pot dispensaries which were deemed as essential businesses, not churches, however. Worshiping God was verboten.

All Christians and other believers must pray to God for an end to the madness thats all around us. Pray for sanity. Pray for Christians and church leaders across the country to hold firm to the immovable, never-changing Word of God. Let us keep in mind the command the Lord gave to Isaiah in a time of national distress for Israel: Do not call conspiracy all that this people calls conspiracy, and do not fear what they fear, nor be in dread. But the LORD of hosts, him you shall honor as holy. (Isaiah 8:12-13).

We also must act in the political sphere. Register to vote. Vote for Conservative religious candidates who will amend the Constitution to ban abortions in all cases but for saving the life of the mother. Vote for candidates who will amend the Title VII Civil Rights Act to declare sex means the traditional definition of sex. Vote for candidates in the Senate who will confirm justices who are originalists. To do this, you must do your homework to find out who those candidates are. Pray and act.

Michael LewinskiDubois

The rest is here:
These judges have opened a can of worms - The Herald

Cell Biology

Scientists find a simpler approach to generate sensory cells of the inner ear – News-Medical.net

Reviewed by Emily Henderson, B.Sc.Jul 1 2020

Scientists from the USC Stem Cell laboratories of Neil Segil and Justin Ichida are whispering the secrets of a simpler way to generate the sensory cells of the inner ear. Their approach uses direct reprogramming to produce sensory cells known as "hair cells," due to their hair-like protrusions that sense sound waves. The study was published today in the journal eLife.

We've succeeded in directly reprogramming a variety of mouse cell types into what we're calling 'induced hair cell-like cells, or iHCs. This allows us to efficiently generate large numbers of iHCs to identify causes and treatments for hearing loss."

Louise Menendez, Ph.D. student, study's lead author

The scientists successfully reprogrammed three different types of mouse cells to become iHCs. The first two types were embryonic and adult versions of connective tissue cells, known as fibroblasts. The third was a different type of inner ear cell, known as a supporting cell.

To achieve reprogramming, the scientists exposed fibroblasts and supporting cells to a cocktail of four transcription factors, which are molecules that help convey the instructions encoded in DNA. The scientists identified this cocktail by testing various combinations of 16 transcription factors that were highly active in the hair cells of newborn mice.

"The four key ingredients turned out to be the transcription factors Six1, Atoh1, Pou4f3, and Gfi1," said Menendez.

The resulting iHCs resembled naturally occurring hair cells in terms of their structure, electrophysiology, and genetic activity. The iHCs also possessed several other distinct characteristics of hair cells, including vulnerability to an antibiotic known to cause hearing loss.

"Hair cells are easy to damage, and currently impossible to repair in humans," said Segil, a professor in the Department of Stem Cell Biology and Regenerative Medicine, and the USC Tina and Rick Caruso Department of Otolaryngology Head and Neck Surgery, and one of the corresponding authors of the study. "Aging, loud noises, and certain chemotherapy drugs and antibiotics can all lead to the permanent loss of hair cells, which is the leading contributor to hearing loss worldwide."

iHCs have the potential to accelerate hearing loss research in at least two important ways, according to Ichida, who is the John Douglas French Alzheimer's Foundation Associate Professor of Stem Cell Biology and Regenerative Medicine at USC, and the other corresponding author of the study.

"In the near term, researchers can use iHCs to screen large numbers of drug candidates that might prevent or treat hearing loss," said Ichida, who is also a New York Stem Cell Foundation-Robertson Investigator. "And further in the future, it could become possible to directly reprogram supporting cells in the inner ear of a deafened individual, as a way to restore hearing."

Source:

Journal reference:

Menendez, L., et al. (2020) Generation of inner ear hair cells by direct lineage conversion of primary somatic cells. eLife. doi.org/10.7554/eLife.55249.

Read more:
Scientists find a simpler approach to generate sensory cells of the inner ear - News-Medical.net

Cell Biology

Outlook on the Array Instruments Global Industry to 2025 – Featuring Affymetrix, Agilent Technologies & Arrayit Among Others -…

DUBLIN--(BUSINESS WIRE)--The "Array Instruments Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

The global array instruments market is currently witnessing strong growth. An array instrument is used in laboratories for quantitatively and simultaneously monitoring the expression of multiple genes. It contains numerous small representative tissue samples from hundreds of different cases, which are assembled on a single histologic slide.

The high-throughput approach of the array instrument aids in locating chromosomal expressions and mutations in a genotype, as well as measuring and detecting gene expressions at the messenger RNA (mRNA) or protein level. As a result, it finds applications in molecular and cell biology, genetics, molecular pathology, and for synthesizing and sequencing nucleic acids.

The increasing prevalence of chronic diseases, in confluence with the emerging need for their early detection and diagnosis, represents one of the key factors driving the global array instruments market growth. In addition to this, governments of several countries are investing in the improvement of healthcare facilities, which in turn, is positively influencing the demand for array instruments, especially in emerging economies.

Furthermore, these instruments can be incorporated with a wide range of technologies, owing to which they find applications in different areas of research, such as life sciences and drug discovery. For instance, deoxyribonucleic acid (DNA) microarrays are used for examining changes in gene expression by fluorescent labeling of complementary DNA, whereas tissue microarrays aid in identifying new diagnostic and prognostic markers and targeting cancer in human beings. Other than this, the introduction of advanced technologies, such as microarray-based comparative genomic hybridization (array CGH), is expected to bolster the market growth in the upcoming years. Looking forward, the publisher expects the market to register a CAGR of around 7% during 2020-2025.

Companies Mentioned

Key Questions Answered in this Report:

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Array Instruments Market

5.1 Market Overview

5.2 Market Performance

5.3 Market Forecast

6 Market Breakup by Application

6.1 Molecular Biology

6.1.1 Market Trends

6.1.2 Market Forecast

6.2 Cell Biology

6.2.1 Market Trends

6.2.2 Market Forecast

6.3 Genetics

6.3.1 Market Trends

6.3.2 Market Forecast

6.4 Molecular Pathology

6.4.1 Market Trends

6.4.2 Market Forecast

6.5 Others

6.5.1 Market Trends

6.5.2 Market Forecast

7 Market Breakup by Technology

7.1 DNA Microarrays

7.1.1 Market Trends

7.1.2 Market Forecast

7.2 Protein Microarrays

7.2.1 Market Trends

7.2.2 Market Forecast

7.3 Cellular Microarrays

7.3.1 Market Trends

7.3.2 Market Forecast

7.4 Tissue Microarrays

7.4.1 Market Trends

7.4.2 Market Forecast

8 Market Breakup by End-User

8.1 Research and Development Laboratories

8.1.1 Market Trends

8.1.2 Market Forecast

8.2 Clinical Diagnostic Labs

8.2.1 Market Trends

8.2.2 Market Forecast

8.3 Agriculture Research Centers

8.3.1 Market Trends

8.3.2 Market Forecast

8.4 Veterinary Laboratories

8.4.1 Market Trends

8.4.2 Market Forecast

8.5 Forensic Centers

8.5.1 Market Trends

8.5.2 Market Forecast

8.6 Others

8.6.1 Market Trends

8.6.2 Market Forecast

9 Market Breakup by Region

9.1 North America

9.2 Asia Pacific

9.3 Europe

9.4 Latin America

9.5 Middle East and Africa

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Indicators

14 Competitive Landscape

14.1 Market Structure

14.2 Key Players

14.3 Profiles of Key Players

For more information about this report visit https://www.researchandmarkets.com/r/f83v23

See original here:
Outlook on the Array Instruments Global Industry to 2025 - Featuring Affymetrix, Agilent Technologies & Arrayit Among Others -...